3D Biology: The paradigm shift in next-generation drug discovery [Interactive infographic]
The drug discovery landscape is changing.
Bringing a drug to market has historically been time-consuming and costly, with many candidates failing in the first phase of clinical trials. Growing evidence suggests that screening compounds early in the process using traditional models – like animals, and cell cultures propagated in 2D – may be a contributing factor. Researchers are now navigating toward complex, human-relevant 3D systems like organoids, as they are believed to better represent how the body might respond to treatment.
Here we dive deeper into why the industry is embracing organoids for next-gen drug discovery and showcase the innovations supporting scientists in their 3D biology journey.
Has this inspired you to explore a transition from 2D to 3D biology? To find solutions for your organoid challenges? Or to scale the work you’re already doing?
Our experts can help. Reach out to us today to get started.